Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 022014
Company: PADAGIS US
Company: PADAGIS US
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
EVAMIST | ESTRADIOL | 1.53MG/SPRAY | SPRAY;TRANSDERMAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/27/2007 | ORIG-1 | Approval | Type 5 - New Formulation or New Manufacturer | STANDARD |
Label (PDF)
Letter (PDF) Review Summary Review (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022014s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022014_evamist_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022014s000_SumR.pdf |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
02/15/2024 | SUPPL-15 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022014s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/022014Orig1s015ltr.pdf | |
08/03/2023 | SUPPL-14 | Labeling-Container/Carton Labels, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022014s014lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022014Orig1s014ltr.pdf | |
11/01/2017 | SUPPL-13 | Labeling-Package Insert |
Label (PDF)
|
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022014s013lbl.pdf | |
01/15/2013 | SUPPL-12 | Manufacturing (CMC) |
Label is not available on this site. |
||
10/26/2011 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022014s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022014s009ltr.pdf | |
03/11/2014 | SUPPL-6 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022014s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022014Orig1s006ltr.pdf | |
10/30/2008 | SUPPL-5 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022014s005ltr.pdf |
04/11/2008 | SUPPL-1 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022014s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022014s001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
02/15/2024 | SUPPL-15 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022014s015lbl.pdf | |
08/03/2023 | SUPPL-14 | Labeling-Container/Carton Labels | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022014s014lbl.pdf | |
08/03/2023 | SUPPL-14 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022014s014lbl.pdf | |
11/01/2017 | SUPPL-13 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022014s013lbl.pdf | |
03/11/2014 | SUPPL-6 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022014s006lbl.pdf | |
10/26/2011 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022014s009lbl.pdf | |
04/11/2008 | SUPPL-1 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022014s001lbl.pdf | |
07/27/2007 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/022014lbl.pdf |